Gentofte Hospital
Hellerup, 2900, Denmark
NCT Number: NCT04125797
This clinical investigation is a single centre, double blinded, case control study in healthy adult females. This study will be conducted in private rooms at Gentofte Hospital (Hjerte-medicinsk Forskning, post 835, Kildegårdsvej 28, 2900 Hellerup).
The investigation centre will enroll 39 subjects including a 20% drop out within a four (4) months period. The subject will not be enrolled before approval of investigation protocol by the local ethics committee.
The subjects need to meet the inclusion and exclusion criteria to be included in this clinical investigation. Each volunteer enrolled in the investigation can only participate once in a procedure. The testing period for each subject will be minimum 72 hours.
The principal investigator's qualifications will be verified through his/her CV. The principal investigator is required to be a medical doctor with at least one year's experience in using similar medical adhesives (e.g. by being experienced in using electrodes where medical adhesives are included) and at least one year's experience with clinical research. In addition, the investigator must be trained in GCP before the study is initiated.
If any subject withdraws from the study, they will not be replaced as drop-out rate is included in the sample size.
Subjects must show up for two sessions, in the first session six adhesives will be placed below the subjects bra. The adhesives will be removed after minimum 72 hours at the second visit. While wearing the adhesives the subjects must keep the investigational area dry. 24, 48 and 72 hours after placement of the adhesives, the subject is asked to completed a questionnaire.
The eCRF must be completed for each subject that has signed the Informed consent form (ICF) and enrolled into this clinical investigation.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Hellerup, 2900, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adhesive will be placed on the subjects skin on the trunk. Placement of the adhesive will be randomized.
Time frame: After a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctor
Did the adhesive stay attached to the skin for 72 hours (Yes/No). For the adhesive to be considered attached (yes) more than 75% adherence should be achieved.
Rate of adhesion on a 5-point scale (no lift off the skin to detached and completely off the skin) 0 = ≥90% adhered (essentially no lift off the skin).
Time frame: 24, 48 and 72 hours after adhesive application
Subject evaluation of itchiness caused by the adhesives at 24, 48, 72 hours measured on visual analogue scale (VAS) (0-10) 0 = 'No itch', 10 = Worst imaginable itch. Adhesives when only including the worst score on each adhesive for each subject
Time frame: After a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctor
Ease of removal on 5-point scale (very difficult to very easy) ; 1: Very difficult; 2: Difficult; 3: Acceptable; 4: Easy; 5: Very easy.
Time frame: After a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctor
Subject evaluation of pain during removal of the adhesives measured on visual analogue scale (0-10). 0= no pain, 10 = Worst possible pain
Time frame: After a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctor
Skin reaction rated on a scale from 0-7 (no evidence of irritation to strong reaction spreading beyond the application site).
0: No evidence of irritation
Time frame: After a minimum of 72 hours (no more than 3 days) after application the adhesives will be removed and assessed by a medical doctor
The number of participants with any adhesive residue left on skin after removal of adhesive (yes/no) after 72 hours.
Ambu A/S
Industry
A Single Centre Comparison Study on Adhesion Properties of Three (3) Skin Adhesives on Healthy, Female, Adult Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details